TGFB1 and metabolic dysfunction-associated steatohepatitis: Similarly, the combination of pentoxifylline and fenofibrate resulted in more beneficial effects on HA, TGF-β, and liver stiffness in NASH patients than fenofibrate alone (El-Haggar and Mostafa, 2015).